Latest filing published 04 Mar 2021 for Affirm Holdings, Inc..
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Khosla Ventures IV, L.P. discloses dealings in 4 companies, chiefly Okta, Inc., Nutanix, Inc. and Guardant Health, Inc. Over a trading history stretching from 5 October 2016 to 2 March 2021, the count stands at 56 filings.
Market trades split into 2 purchases (€3.0M) and 8 sales (€11.9M). On balance, insiders were net sellers of €8.9M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2021, the count stands at 2 purchases and no sales.
On 4 March 2021 came the latest disclosure, a transaction in Affirm Holdings, Inc. The clock since the last published purchase (15 January 2021) now reads 2,107 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 56 declarations